A Phase I Study of Rituximab, Lenalidomide, and Ibrutinib in Previously Untreated Follicular Lymphoma
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 30 May 2017
At a glance
- Drugs Ibrutinib (Primary) ; Lenalidomide (Primary) ; Rituximab
- Indications Follicular lymphoma
- Focus Adverse reactions
- 03 Oct 2016 Results published in the Blood.
- 08 Dec 2015 Results (n=22) presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.
- 07 Dec 2015 Results will be presented at the 57th Annual American Society of Hematology (ASH) Meeting and Exposition, as per AbbVie media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History